Galectins: Important Regulators in Normal and Pathologic Pregnancies
Open Access
- 3 September 2022
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (17) , 10110
Abstract
Galectins (Gal) are characterized by their affinity for galactoside structures on glycoconjugates. This relationship is mediated by carbohydrate recognition domains, which are multifunctional regulators of basic cellular biological processes with high structural similarity among family members. They participate in both innate and adaptive immune responses, as well as in reproductive immunology. Recently, the discovery that galectins are highly expressed at the maternal–fetal interface has garnerd the interest of experts in human reproduction. Galectins are involved in a variety of functions such as maternal–fetal immune tolerance, angiogenesis, trophoblast invasion and placental development and are considered to be important mediators of successful embryo implantation and during pregnancy. Dysregulation of these galectins is associated with abnormal and pathological pregnancies (e.g., preeclampsia, gestational diabetes mellitus, fetal growth restriction, preterm birth). Our work reviews the regulatory mechanisms of galectins in normal and pathological pregnancies and has implications for clinicians in the prevention, diagnosis and treatment of pregnancy-related diseases.Keywords
Funding Information
- National Natural Science Foundation of China (81971362, 92057119, 31970798)
- Zhuoxue of Fudan University (JIF157602)
- Fudan University (IDF157014/002)
This publication has 184 references indexed in Scilit:
- The antibiotic treatment of PPROM study: systemic maternal and fetal markers and perinatal outcomesAmerican Journal of Obstetrics and Gynecology, 2012
- Galectins: guardians of eutherian pregnancy at the maternal–fetal interfaceTrends in Endocrinology & Metabolism, 2012
- Galectin-3 in cord blood of term and preterm infantsClinical and Experimental Immunology, 2011
- Placental protein 13 (PP13/galectin-13) undergoes lipid raft-associated subcellular redistribution in the syncytiotrophoblast in preterm preeclampsia and HELLP syndromeAmerican Journal of Obstetrics and Gynecology, 2011
- Dynamics of galectin-3 in the nucleus and cytoplasmBiochimica et Biophysica Acta (BBA) - General Subjects, 2010
- A primate subfamily of galectins expressed at the maternal–fetal interface that promote immune cell deathProceedings of the National Academy of Sciences, 2009
- T cell apoptosis at the maternal–fetal interface in early human pregnancy, involvement of galectin-1Proceedings of the National Academy of Sciences, 2008
- Emergence of hormonal and redox regulation of galectin-1 in placental mammals: Implication in maternal–fetal immune toleranceProceedings of the National Academy of Sciences, 2008
- Placental protein 13 (galectin-13) has decreased placental expression but increased shedding and maternal serum concentrations in patients presenting with preterm pre-eclampsia and HELLP syndromeVirchows Archiv, 2008
- Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapyProceedings of the National Academy of Sciences, 2006